{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:14:31Z","timestamp":1792602871422,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Currently, the treatment and prevention of migraine remain highly challenging. Mendelian randomization (MR) has been widely used to explore novel therapeutic targets. Therefore, we performed a systematic druggable genome-wide MR to explore the potential therapeutic targets for migraine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We obtained data on druggable genes and screened for genes within brain expression quantitative trait locis (eQTLs) and blood eQTLs, which were then subjected to two-sample MR analysis and colocalization analysis with migraine genome-wide association studies data to identify genes highly associated with migraine. In addition, phenome-wide research, enrichment analysis, protein network construction, drug prediction, and molecular docking were performed to provide valuable guidance for the development of more effective and targeted therapeutic drugs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 21 druggable genes significantly associated with migraine (BRPF3, CBFB, CDK4, CHD4, DDIT4, EP300, EPHA5, FGFRL1, FXN, HMGCR, HVCN1, KCNK5, MRGPRE, NLGN2, NR1D1, PLXNB1, TGFB1, TGFB3, THRA, TLN1 and TP53), two of which were significant in both blood and brain (HMGCR and TGFB3). The results of phenome-wide research showed that HMGCR was highly correlated with low-density lipoprotein, and TGFB3 was primarily associated with insulin-like growth factor 1 levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study utilized MR and colocalization analysis to identify 21 potential drug targets for migraine, two of which were significant in both blood and brain. These findings provide promising leads for more effective migraine treatments, potentially reducing drug development costs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-024-01805-3","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T08:01:57Z","timestamp":1718179317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization"],"prefix":"10.1186","volume":"25","author":[{"given":"Chengcheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"1805_CR1","doi-asserted-by":"publisher","unstructured":"(2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"issue":"5","key":"1805_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/s1474-4422(18)30499-x","volume":"18","author":"GBD Neurology Collaborators","year":"2019","unstructured":"GBD Neurology Collaborators (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18(5):459\u2013480. https:\/\/doi.org\/10.1016\/s1474-4422(18)30499-x","journal-title":"Lancet Neurol."},{"issue":"1","key":"1805_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s42003-021-02356-y","volume":"4","author":"H Choquet","year":"2021","unstructured":"Choquet H, Yin J, Jacobson AS, Horton BH, Hoffmann TJ, Jorgenson E et al (2021) New and sex-specific migraine susceptibility loci identified from a multiethnic genome-wide meta-analysis. Commun Biol 4(1):864. https:\/\/doi.org\/10.1038\/s42003-021-02356-y","journal-title":"Commun Biol"},{"key":"1805_CR4","doi-asserted-by":"crossref","unstructured":"Tanaka M, Szab\u00f3 \u00c1, K\u00f6rt\u00e9si T, Szok D, Tajti J, V\u00e9csei L (2023) From CGRP to PACAP, VIP, and beyond: unraveling the next chapters in migraine treatment. Cells 12(22).\u00a0http:\/\/doi.org\/10.3390\/cells12222649.","DOI":"10.3390\/cells12222649"},{"issue":"2","key":"1805_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41588-021-00990-0","volume":"54","author":"H Hautakangas","year":"2022","unstructured":"Hautakangas H, Winsvold BS, Ruotsalainen SE, Bjornsdottir G, Harder AVE, Kogelman LJA et al (2022) Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nat Genet 54(2):152\u2013160. https:\/\/doi.org\/10.1038\/s41588-021-00990-0","journal-title":"Nat Genet"},{"key":"1805_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2024.04.008","author":"T Qi","year":"2024","unstructured":"Qi T, Song L, Guo Y, Chen C, Yang J (2024) From genetic associations to genes: methods, applications, and challenges. Trends Genet. https:\/\/doi.org\/10.1016\/j.tig.2024.04.008","journal-title":"Trends Genet"},{"issue":"10","key":"1805_CR7","doi-asserted-by":"publisher","first-page":"100190","DOI":"10.1016\/j.xgen.2022.100190","volume":"2","author":"S Namba","year":"2022","unstructured":"Namba S, Konuma T, Wu KH, Zhou W, Okada Y (2022) A practical guideline of genomics-driven drug discovery in the era of global biobank meta-analysis. Cell Genom 2(10):100190. https:\/\/doi.org\/10.1016\/j.xgen.2022.100190","journal-title":"Cell Genom"},{"issue":"2","key":"1805_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/ije\/dyv108","volume":"44","author":"S Burgess","year":"2015","unstructured":"Burgess S, Timpson NJ, Ebrahim S, Davey Smith G (2015) Mendelian randomization: where are we now and where are we going? Int J Epidemiol 44(2):379\u2013388. https:\/\/doi.org\/10.1093\/ije\/dyv108","journal-title":"Int J Epidemiol"},{"issue":"1","key":"1805_CR9","doi-asserted-by":"publisher","first-page":"7342","DOI":"10.1038\/s41467-021-26280-1","volume":"12","author":"CS Storm","year":"2021","unstructured":"Storm CS, Kia DA, Almramhi MM, Bandres-Ciga S, Finan C, Hingorani AD et al (2021) Finding genetically-supported drug targets for Parkinson\u2019s disease using Mendelian randomization of the druggable genome. Nat Commun 12(1):7342. https:\/\/doi.org\/10.1038\/s41467-021-26280-1","journal-title":"Nat Commun"},{"issue":"D1","key":"1805_CR10","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","volume":"49","author":"SL Freshour","year":"2021","unstructured":"Freshour SL, Kiwala S, Cotto KC, Coffman AC, McMichael JF, Song JJ et al (2021) Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res 49(D1):D1144\u2013d1151. https:\/\/doi.org\/10.1093\/nar\/gkaa1084","journal-title":"Nucleic Acids Res"},{"key":"1805_CR11","doi-asserted-by":"crossref","unstructured":"Finan C, Gaulton A, Kruger F A, Lumbers R T, Shah T, Engmann J, et al. (2017) The druggable genome and support for target identification and validation in drug development. Sci Transl Med 9(383).\u00a0http:\/\/doi.org\/10.1126\/scitranslmed.aag1166.","DOI":"10.1126\/scitranslmed.aag1166"},{"issue":"11","key":"1805_CR12","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/jnnp-2023-331142","volume":"94","author":"WM Su","year":"2023","unstructured":"Su WM, Gu XJ, Dou M, Duan QQ, Jiang Z, Yin KF et al (2023) Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 94(11):954\u2013961. https:\/\/doi.org\/10.1136\/jnnp-2023-331142","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"1805_CR13","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra HJ, Bonder MJ, Deelen P, Zeng B et al (2021) Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet 53(9):1300\u20131310. https:\/\/doi.org\/10.1038\/s41588-021-00913-z","journal-title":"Nat Genet"},{"key":"1805_CR14","doi-asserted-by":"crossref","unstructured":"Wang D, Liu S, Warrell J, Won H, Shi X, Navarro F C P, et al. (2018) Comprehensive functional genomic resource and integrative model for the human brain. Science 362(6420).\u00a0http:\/\/doi.org\/10.1126\/science.aat8464.","DOI":"10.1126\/science.aat8464"},{"key":"1805_CR15","doi-asserted-by":"crossref","unstructured":"Hemani G, Zheng J, Elsworth B, Wade K H, Haberland V, Baird D, et al. (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7.\u00a0http:\/\/doi.org\/10.7554\/eLife.34408.","DOI":"10.7554\/eLife.34408"},{"key":"1805_CR16","doi-asserted-by":"crossref","unstructured":"Consortium. G P, Auton A, Brooks L D, Durbin R M, Garrison E P, Kang H M, et al 2015 A global reference for human genetic variation. Nature 526(7571):68-74. http:\/\/doi.org\/10.1038\/nature15393","DOI":"10.1038\/nature15393"},{"issue":"20","key":"1805_CR17","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1093\/bioinformatics\/btw373","volume":"32","author":"JR Staley","year":"2016","unstructured":"Staley JR, Blackshaw J, Kamat MA, Ellis S, Surendran P, Sun BB et al (2016) PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics 32(20):3207\u20133209. https:\/\/doi.org\/10.1093\/bioinformatics\/btw373","journal-title":"Bioinformatics"},{"key":"1805_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.12688\/wellcomeopenres.15555.3","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess S, Davey Smith G, Davies NM, Dudbridge F, Gill D, Glymour MM et al (2019) Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res 4:186. https:\/\/doi.org\/10.12688\/wellcomeopenres.15555.3","journal-title":"Wellcome Open Res"},{"issue":"21","key":"1805_CR19","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/sim.6522","volume":"34","author":"MF Greco","year":"2015","unstructured":"Greco MF, Minelli C, Sheehan NA, Thompson JR (2015) Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. Stat Med 34(21):2926\u20132940. https:\/\/doi.org\/10.1002\/sim.6522","journal-title":"Stat Med"},{"issue":"2","key":"1805_CR20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512\u2013525. https:\/\/doi.org\/10.1093\/ije\/dyv080","journal-title":"Int J Epidemiol"},{"issue":"5","key":"1805_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C et al (2014) Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 10(5):e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383","journal-title":"PLoS Genet"},{"issue":"5","key":"1805_CR22","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118","journal-title":"OMICS"},{"issue":"D1","key":"1805_CR23","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R et al (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51(D1):D638\u2013d646. https:\/\/doi.org\/10.1093\/nar\/gkac1000","journal-title":"Nucleic Acids Res"},{"issue":"18","key":"1805_CR24","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo M, Shin J, Kim J, Ryall KA, Lee K, Lee S et al (2015) DSigDB: drug signatures database for gene set analysis. Bioinformatics 31(18):3069\u20133071. https:\/\/doi.org\/10.1093\/bioinformatics\/btv313","journal-title":"Bioinformatics"},{"issue":"D1","key":"1805_CR25","doi-asserted-by":"publisher","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","volume":"51","author":"S Kim","year":"2023","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S et al (2023) PubChem 2023 update. Nucleic Acids Res 51(D1):D1373\u2013d1380. https:\/\/doi.org\/10.1093\/nar\/gkac956","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"1805_CR26","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS et al (2009) AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"issue":"23","key":"1805_CR27","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1111\/bph.15657","volume":"178","author":"F Zobdeh","year":"2021","unstructured":"Zobdeh F, Ben Kraiem A, Attwood MM, Chubarev VN, Tarasov VV, Schi\u00f6th HB et al (2021) Pharmacological treatment of migraine: drug classes, mechanisms of action, clinical trials and new treatments. Br J Pharmacol 178(23):4588\u20134607. https:\/\/doi.org\/10.1111\/bph.15657","journal-title":"Br J Pharmacol"},{"key":"1805_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","volume":"165\u2013166","author":"R Pandit","year":"2020","unstructured":"Pandit R, Chen L, G\u00f6tz J (2020) The blood-brain barrier: physiology and strategies for drug delivery. Adv Drug Deliv Rev 165\u2013166:1\u201314. https:\/\/doi.org\/10.1016\/j.addr.2019.11.009","journal-title":"Adv Drug Deliv Rev"},{"issue":"22","key":"1805_CR29","doi-asserted-by":"publisher","first-page":"e2223","DOI":"10.1212\/wnl.0000000000012919","volume":"97","author":"Y Guo","year":"2021","unstructured":"Guo Y, Daghlas I, Gormley P, Giulianini F, Ridker PM, Mora S et al (2021) Phenotypic and Genotypic Associations Between Migraine and Lipoprotein Subfractions. Neurology 97(22):e2223\u2013e2235. https:\/\/doi.org\/10.1212\/wnl.0000000000012919","journal-title":"Neurology"},{"key":"1805_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.2235","author":"P Hong","year":"2024","unstructured":"Hong P, Han L, Wan Y (2024) Mendelian randomization study of lipid metabolism characteristics and migraine risk. Eur J Pain. https:\/\/doi.org\/10.1002\/ejp.2235","journal-title":"Eur J Pain"},{"issue":"6","key":"1805_CR31","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/ana.24534","volume":"78","author":"C Buettner","year":"2015","unstructured":"Buettner C, Nir RR, Bertisch SM, Bernstein C, Schain A, Mittleman MA et al (2015) Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial. Ann Neurol 78(6):970\u2013981. https:\/\/doi.org\/10.1002\/ana.24534","journal-title":"Ann Neurol"},{"issue":"1","key":"1805_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s1474-4422(14)70220-0","volume":"14","author":"MD Ferrari","year":"2015","unstructured":"Ferrari MD, Klever RR, Terwindt GM, Ayata C, van den Maagdenberg AM (2015) Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol 14(1):65\u201380. https:\/\/doi.org\/10.1016\/s1474-4422(14)70220-0","journal-title":"Lancet Neurol"},{"issue":"1","key":"1805_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s10194-021-01271-1","volume":"22","author":"O Kursun","year":"2021","unstructured":"Kursun O, Yemisci M, van den Maagdenberg A, Karatas H (2021) Migraine and neuroinflammation: the inflammasome perspective. J Headache Pain 22(1):55. https:\/\/doi.org\/10.1186\/s10194-021-01271-1","journal-title":"J Headache Pain"},{"issue":"2","key":"1805_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.it.2006.12.003","volume":"28","author":"J Greenwood","year":"2007","unstructured":"Greenwood J, Mason JC (2007) Statins and the vascular endothelial inflammatory response. Trends Immunol 28(2):88\u201398. https:\/\/doi.org\/10.1016\/j.it.2006.12.003","journal-title":"Trends Immunol"},{"issue":"43","key":"1805_CR35","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1805_CR36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J et al (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34(3):267\u2013273. https:\/\/doi.org\/10.1038\/ng1180","journal-title":"Nat Genet"},{"issue":"4","key":"1805_CR37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.coph.2009.04.008","volume":"9","author":"S Sanjabi","year":"2009","unstructured":"Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA (2009) Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 9(4):447\u2013453. https:\/\/doi.org\/10.1016\/j.coph.2009.04.008","journal-title":"Curr Opin Pharmacol"},{"key":"1805_CR38","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.1038\/ncomms7329","volume":"6","author":"T Okamura","year":"2015","unstructured":"Okamura T, Sumitomo S, Morita K, Iwasaki Y, Inoue M, Nakachi S et al (2015) TGF-\u03b23-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses. Nat Commun 6:6329. https:\/\/doi.org\/10.1038\/ncomms7329","journal-title":"Nat Commun"},{"issue":"1","key":"1805_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s10194-023-01707-w","volume":"25","author":"S Sun","year":"2024","unstructured":"Sun S, Fan Z, Liu X, Wang L, Ge Z (2024) Microglia TREM1-mediated neuroinflammation contributes to central sensitization via the NF-\u03baB pathway in a chronic migraine model. J Headache Pain 25(1):3. https:\/\/doi.org\/10.1186\/s10194-023-01707-w","journal-title":"J Headache Pain"},{"issue":"4","key":"1805_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.5114\/ninp.2013.36760","volume":"47","author":"I G\u00fczel","year":"2013","unstructured":"G\u00fczel I, Ta\u015fdemir N, Celik Y (2013) Evaluation of serum transforming growth factor \u03b21 and C-reactive protein levels in migraine patients. Neurol Neurochir Pol 47(4):357\u2013362. https:\/\/doi.org\/10.5114\/ninp.2013.36760","journal-title":"Neurol Neurochir Pol"},{"issue":"9","key":"1805_CR41","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1111\/j.1526-4610.2005.00246.x","volume":"45","author":"K Ishizaki","year":"2005","unstructured":"Ishizaki K, Takeshima T, Fukuhara Y, Araki H, Nakaso K, Kusumi M et al (2005) Increased plasma transforming growth factor-beta1 in migraine. Headache 45(9):1224\u20131228. https:\/\/doi.org\/10.1111\/j.1526-4610.2005.00246.x","journal-title":"Headache"},{"issue":"3","key":"1805_CR42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1468-2982.2008.01727.x","volume":"29","author":"SH B\u00f8","year":"2009","unstructured":"B\u00f8 SH, Davidsen EM, Gulbrandsen P, Dietrichs E, Bovim G, Stovner LJ et al (2009) Cerebrospinal fluid cytokine levels in migraine, tension-type headache and cervicogenic headache. Cephalalgia 29(3):365\u2013372. https:\/\/doi.org\/10.1111\/j.1468-2982.2008.01727.x","journal-title":"Cephalalgia"},{"issue":"8","key":"1805_CR43","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/head.14599","volume":"63","author":"L Yang","year":"2023","unstructured":"Yang L, Zhou Y, Zhang L, Wang Y, Zhang Y, Xiao Z (2023) Aryl hydrocarbon receptors improve migraine-like pain behaviors in rats through the regulation of regulatory T cell\/T-helper 17 cell-related homeostasis. Headache 63(8):1045\u20131060. https:\/\/doi.org\/10.1111\/head.14599","journal-title":"Headache"},{"issue":"8","key":"1805_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082261","volume":"19","author":"T Komai","year":"2018","unstructured":"Komai T, Okamura T, Inoue M, Yamamoto K, Fujio K (2018) Reevaluation of pluripotent cytokine TGF-\u03b23 in immunity. Int J Mol Sci 19(8):2261. https:\/\/doi.org\/10.3390\/ijms19082261","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1805_CR45","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s40120-022-00398-w","volume":"11","author":"R Abuduxukuer","year":"2022","unstructured":"Abuduxukuer R, Niu PP, Guo ZN, Xu YM, Yang Y (2022) Circulating insulin-like growth factor 1 levels and migraine risk: a mendelian randomization study. Neurol Ther 11(4):1677\u20131689. https:\/\/doi.org\/10.1007\/s40120-022-00398-w","journal-title":"Neurol Ther"},{"key":"1805_CR46","doi-asserted-by":"publisher","first-page":"133362","DOI":"10.1016\/j.jhazmat.2023.133362","volume":"465","author":"S Ye","year":"2024","unstructured":"Ye S, Wei L, Jiang Y, Yuan Y, Zeng Y, Zhu L et al (2024) Mechanism of NO(2)-induced migraine in rats: The exploration of the role of miR-653-3p\/IGF1 axis. J Hazard Mater 465:133362. https:\/\/doi.org\/10.1016\/j.jhazmat.2023.133362","journal-title":"J Hazard Mater"},{"issue":"4","key":"1805_CR47","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12774","volume":"17","author":"J Ji","year":"2018","unstructured":"Ji J, Xue TF, Guo XD, Yang J, Guo RB, Wang J et al (2018) Antagonizing peroxisome proliferator-activated receptor \u03b3 facilitates M1-to-M2 shift of microglia by enhancing autophagy via the LKB1-AMPK signaling pathway. Aging Cell 17(4):e12774. https:\/\/doi.org\/10.1111\/acel.12774","journal-title":"Aging Cell"},{"issue":"8","key":"1805_CR48","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1111\/head.13934","volume":"60","author":"AA Gelfand","year":"2020","unstructured":"Gelfand AA, Ross AC, Irwin SL, Greene KA, Qubty WF, Allen IE (2020) Melatonin for Acute Treatment of Migraine in Children and Adolescents: A Pilot Randomized Trial. Headache 60(8):1712\u20131721. https:\/\/doi.org\/10.1111\/head.13934","journal-title":"Headache"},{"issue":"9","key":"1805_CR49","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1055\/s-0042-1755320","volume":"80","author":"PSF Santos","year":"2022","unstructured":"Santos PSF, Melhado EM, Kaup AO, Costa A, Roesler CAP, Piovesan \u00c9J et al (2022) Consensus of the Brazilian Headache Society (SBCe) for prophylactic treatment of episodic migraine: part II. Arq Neuropsiquiatr 80(9):953\u2013969. https:\/\/doi.org\/10.1055\/s-0042-1755320","journal-title":"Arq Neuropsiquiatr"},{"issue":"17","key":"1805_CR50","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1212\/WNL.0b013e3181f9618c","volume":"75","author":"KB Alstadhaug","year":"2010","unstructured":"Alstadhaug KB, Odeh F, Salvesen R, Bekkelund SI (2010) Prophylaxis of migraine with melatonin: a randomized controlled trial. Neurology 75(17):1527\u20131532. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f9618c","journal-title":"Neurology"},{"issue":"2","key":"1805_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1941874412439583","volume":"2","author":"AA Gelfand","year":"2012","unstructured":"Gelfand AA, Goadsby PJ (2012) A neurologist\u2019s guide to acute migraine therapy in the emergency room. Neurohospitalist 2(2):51\u201359. https:\/\/doi.org\/10.1177\/1941874412439583","journal-title":"Neurohospitalist"},{"issue":"6","key":"1805_CR52","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/head.12835","volume":"56","author":"SL Orr","year":"2016","unstructured":"Orr SL, Friedman BW, Christie S, Minen MT, Bamford C, Kelley NE et al (2016) Management of Adults With Acute Migraine in the Emergency Department: The American Headache Society Evidence Assessment of Parenteral Pharmacotherapies. Headache 56(6):911\u2013940. https:\/\/doi.org\/10.1111\/head.12835","journal-title":"Headache"},{"issue":"3","key":"1805_CR53","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1526-4610.2007.00959.x","volume":"48","author":"BH Rowe","year":"2008","unstructured":"Rowe BH, Colman I, Edmonds ML, Blitz S, Walker A, Wiens S (2008) Randomized controlled trial of intravenous dexamethasone to prevent relapse in acute migraine headache. Headache 48(3):333\u2013340. https:\/\/doi.org\/10.1111\/j.1526-4610.2007.00959.x","journal-title":"Headache"},{"issue":"2","key":"1805_CR54","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/tox.22861","volume":"35","author":"AA Oyagbemi","year":"2020","unstructured":"Oyagbemi AA, Adebiyi OE, Adigun KO, Ogunpolu BS, Falayi OO, Hassan FO et al (2020) Clofibrate, a PPAR-\u03b1 agonist, abrogates sodium fluoride-induced neuroinflammation, oxidative stress, and motor incoordination via modulation of GFAP\/Iba-1\/anti-calbindin signaling pathways. Environ Toxicol 35(2):242\u2013253. https:\/\/doi.org\/10.1002\/tox.22861","journal-title":"Environ Toxicol"},{"key":"1805_CR55","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Aguilar M, Ibarra-Lara L, Cano-Mart\u00ednez A, Soria-Castro E, Castrej\u00f3n-T\u00e9llez V, Pav\u00f3n N, et al. (2023) PPAR Alpha Activation by Clofibrate Alleviates Ischemia\/Reperfusion Injury in Metabolic Syndrome Rats by Decreasing Cardiac Inflammation and Remodeling and by Regulating the Atrial Natriuretic Peptide Compensatory Response. Int J Mol Sci 24(6).\u00a0http:\/\/doi.org\/10.3390\/ijms24065321.","DOI":"10.3390\/ijms24065321"},{"issue":"4","key":"1805_CR56","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1161\/circulationaha.104.475673","volume":"115","author":"JD Brown","year":"2007","unstructured":"Brown JD, Plutzky J (2007) Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation 115(4):518\u2013533. https:\/\/doi.org\/10.1161\/circulationaha.104.475673","journal-title":"Circulation"},{"issue":"1","key":"1805_CR57","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s10194-021-01382-9","volume":"23","author":"L Zhang","year":"2022","unstructured":"Zhang L, Lu C, Kang L, Li Y, Tang W, Zhao D et al (2022) Temporal characteristics of astrocytic activation in the TNC in a mice model of pain induced by recurrent dural infusion of inflammatory soup. J Headache Pain 23(1):8. https:\/\/doi.org\/10.1186\/s10194-021-01382-9","journal-title":"J Headache Pain"},{"issue":"4","key":"1805_CR58","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s10787-021-00843-6","volume":"29","author":"R Patel","year":"2021","unstructured":"Patel R, Kaur K, Singh S (2021) Protective effect of andrographolide against STZ induced Alzheimer\u2019s disease in experimental rats: possible neuromodulation and A\u03b2((1\u201342)) analysis. Inflammopharmacology 29(4):1157\u20131168. https:\/\/doi.org\/10.1007\/s10787-021-00843-6","journal-title":"Inflammopharmacology"},{"key":"1805_CR59","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbi.2020.09.017","volume":"91","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Kwatra M, Ranjan Panda S, Murty USN, Naidu VGM (2021) Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease. Brain Behav Immun 91:142\u2013158. https:\/\/doi.org\/10.1016\/j.bbi.2020.09.017","journal-title":"Brain Behav Immun"},{"issue":"1","key":"1805_CR60","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12883-020-01745-w","volume":"20","author":"E Ciampi","year":"2020","unstructured":"Ciampi E, Uribe-San-Martin R, C\u00e1rcamo C, Cruz JP, Reyes A, Reyes D et al (2020) Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial. BMC Neurol 20(1):173. https:\/\/doi.org\/10.1186\/s12883-020-01745-w","journal-title":"BMC Neurol"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01805-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01805-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01805-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T08:02:08Z","timestamp":1718179328000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01805-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1805"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01805-3","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"assertion":[{"value":"5 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All data analyzed during this study have been previously published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}